ReferIndia News AstraZeneca Earmarks ₹176 Cr Investments in India; to Boost GITC in Chennai

ReferIndia News

Want to grow your business digitally?

Let us help you get there—fast, smart, and effective.

Contact Now
News Image

AstraZeneca Earmarks ₹176 Cr Investments in India; to Boost GITC in Chennai

Published on: Sept. 6, 2025, 2:05 p.m. | Source: Outlook Business

Global bio-pharmaceutical company AstraZeneca has committed investments of ₹176 crore in India, which includes expansion of its Global Innovation and Technology Centre in chennai

Checkout more news
Ad Banner

Growth Housing by HoABL

100% buy back of if you feel home is not right for you for the same price which you paid.

Book Now
ReferIndia News contact